Single quad lcms system with elsd capability

Ended Awarded

Contract number
75N95022F00133
Awardee
Awarding agency
Obligated
$159,034

Award facts

Contract value 100% obligated
$159,034.01 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Marshallton, DE 19808, USA
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price delivery order to Agilent Technologies Inc. Customer Service And Sales Division for a single quad liquid chromatography mass spectrometry (LCMS) system with evaporative light-scattering detector (ELSD) capability. The potential value of the contract is $159,034.01. This award is not set aside and is issued under Agilent's existing Multiple Award Schedule (MAS) contract. Agilent Technologies, Inc., the parent company of the awardee, has provided analytical instruments, equipment maintenance, and related services to various federal agencies including the Departments of Defense, Justice, and Veterans Affairs. The LCMS system is likely being procured to support research and testing capabilities at the National Center for Advancing Translational Sciences, which focuses on accelerating the development and delivery of new treatments.

Quick answers

Who was awarded contract 75N95022F00133?

75N95022F00133 was awarded to Agilent Technologies Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 28, 2022.

How much is contract 75N95022F00133 worth?

The government has obligated $159,034 on 75N95022F00133.

Which agency awarded contract 75N95022F00133?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00133, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N95022F00133 an order under another contract?

Yes. 75N95022F00133 is a delivery order under GS07F0564X, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75N95022F00133 competed?

The extent of competition for 75N95022F00133 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award